Recherche
-
Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments
(Seminars in Arthritis and Rheumatism. vol. 51, n° 1, pp. 36-42, 2021-02)Article de revue -
Update on the cellular pathogenesis of lupus
(Current Opinion in Rheumatology. vol. 33, n° 2, pp. 190-196, 2021-03)Article de revue -
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
(The Lancet Rheumatology. vol. 3, n° 6, pp. e419-e426, 2021-06)Article de revue -
Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis
(AUTOIMMUNITY REVIEWS. vol. 20, n° 10, 2021)Article de revue -
Locoregional treatments for digital ulcers in systemic sclerosis: A systematic review
(Acta Dermato-Venereologica. vol. 101, n° 6, 2021-05-27)Article de revueLibre accès -
Evaluating filgotinib for the treatment of rheumatoid arthritis
(Expert Opinion on Pharmacotherapy. vol. 22, n° 18, pp. 2435–2444, 2021-08-26)Article de revue -
TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis
(Annals of the rheumatic diseases. vol. 80, n° 12, pp. 1594-1603, 2021-12)Article de revueLibre accès